Results 321 to 330 of about 154,558 (375)

Fractionated Stereotactic Intensity-Modulated Radiotherapy for Large Brain Metastases: Comprehensive Analyses of Dose-Volume Predictors of Radiation-Induced Brain Necrosis. [PDF]

Cancers (Basel)
Murai T, Kasai Y, Eguchi Y, Takano S, Kita N, Torii A, Takaoka T, Tomita N, Shibamoto Y, Hiwatashi A.   +9 more
europepmc   +1 more source

Applying mixed-integer linear programming to the non-coplanar beam angle optimization of intensity-modulated radiotherapy for liver cancer. [PDF]

Quant Imaging Med Surg
Huang P, Shang J, Xie X, Hu Z, Liu Z, Yan H.   +5 more
europepmc   +1 more source

Comparison of long-term quality of life and their predictors in survivors between paediatric and adult nasopharyngeal carcinoma in the intensity-modulated radiotherapy era. [PDF]

BMC Cancer
Jin J, Guo SS, Liu LT, Wen DX, Liu RP, Lin JY, Liu SQ, Sun XS, Liang YJ, Tang LQ, Mai HQ, Chen QY.   +11 more
europepmc   +1 more source

The impact of plan complexity on calculation and measurement-based pre-treatment verifications for sliding-window intensity-modulated radiotherapy. [PDF]

Phys Imaging Radiat Oncol
Li S, Luo H, Tan X, Qiu T, Yang X, Feng B, Chen L, Wang Y, Jin F.   +8 more
europepmc   +1 more source

Comparing Dosimetry of Heart and Left Anterior Descending Artery Exposure in Carcinoma Esophagus Patients: Volumetric Arc Therapy Versus Intensity-Modulated Radiotherapy. [PDF]

Cureus
Mishra V, Chaudhary S, Singh P, Pandey L, Pandey A, Chatterjee R.   +5 more
europepmc   +1 more source

Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer: A Secondary Analysis of a Randomized Clinical Trial.

JAMA Oncol
Chun SG, Hu C, Komaki RU, Timmerman RD, Schild SE, Bogart JA, Dobelbower MC, Bosch W, Kavadi VS, Narayan S, Iyengar P, Robinson C, Rothman J, Raben A, Augspurger ME, MacRae RM, Paulus R, Bradley JD.   +17 more
europepmc   +1 more source

Postoperative Hypofractionated Intensity-Modulated Radiotherapy With Concurrent Chemotherapy in Cervical Cancer: The POHIM-CCRT Nonrandomized Controlled Trial.

JAMA Oncol
Cho WK, Park W, Kim SW, Lee KK, Ahn KJ, Choi JH.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Late Toxicity After Adjuvant Conventional Radiation Versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER): A Randomized Controlled Trial

Journal of Clinical Oncology, 2021
PURPOSE Postoperative Adjuvant Radiation in Cervical Cancer (PARCER), a phase III randomized trial, compared late toxicity after image-guided intensity-modulated radiotherapy (IG-IMRT) with three-dimensional conformal radiation therapy (3D-CRT) in women ...
S. Chopra, Sudeep Gupta, S. Kannan, T. Dora, R. Engineer, A. Mangaj, A. Maheshwari, T. Shylasree, J. Ghosh, S. Paul, R. Phurailatpam, M. Charnalia, Mitali Alone, J. Swamidas, U. Mahantshetty, K. Deodhar, R. Kerkar, S. Shrivastava   +17 more
semanticscholar   +1 more source

Gradients and intensity modulated radiotherapy [PDF]

Proceedings of the 22nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (Cat. No.00CH37143), 2002
A consequence of the advent of intensity modulated radiation therapy (IMRT) is the presence of large dose gradients surrounding the tumor, and the regions at risk (RAR's) near the tumor. Unlike standard radiotherapy, these gradients are not the chance result of a few beam choices, but rather they are strategically placed by the optimization software. A
Gustavo H. Olivera, J. Balog, Paul J. Reckwerdt, Thomas R. Mackie, J M Kapatoes, H. Keller   +5 more
openaire   +1 more source